MYCN and neuroblastoma: Approximately 20% of NB tumors display amplification of the MYCN oncogene, whereas the remaining cases are not MYCN amplified although displaying other structural chromosomal rearrangements (such as 3p, 4p, 11q losses and 1q, 2p, 17q gains) with or without numerical aberrations (Maris, 2010).